FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the FDA had issued an Emergency Use Authorization (EUA) for Philips’ IntelliVue Patient Monitors MX750/MX850 and its IntelliVue Active Displays AD75/AD85, for use in the US during the COVID-19 health emergency.
These patient monitoring solutions support infection-control protocols and remotely provide critical patient information for caregivers, capabilities that are much needed when caring for hospitalized COVID-19 patients.
Tags:
Source: Royal Philips
Credit: https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20200612-philips-launches-obstetric-monitoring-solution-to-support-clinicians-and-expectant-mothers-during-covid-19-pandemic.html?src=search
